Bicara Therapeutics Inc. (BCAX) Insider Trading Disclosures
Bicara Therapeutics Inc. (BCAX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BCAX
CIK: 2023658
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerMichael Petry
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0001897612-26-000635 | View SEC Doc Filr Page |
| 4 | 2026-09-10 | 2026-09-08 | FORM 4 | 0001470831-26-000883 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001969223-26-001009 | View SEC Doc Filr Page |
| 144 | 2026-09-08 | — | 144 Filing | 0001969223-26-001008 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-21 | 8-K | 0001628280-26-058937 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001470831-26-000819 | View SEC Doc Filr Page |
| 3 | 2026-08-14 | 2026-08-12 | FORM 3 | 0001470831-26-000818 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0001274173-26-000198 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001470831-26-000814 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001470831-26-000813 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | FORM 4 | 0001470831-26-000812 | View SEC Doc Filr Page |
| S-8 | 2026-08-11 | — | S-8 | 0001628280-26-055779 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001628280-26-055765 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001628280-26-055500 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001969223-26-000873 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001969223-26-000872 | View SEC Doc Filr Page |
| 144 | 2026-08-10 | — | 144 Filing | 0001969223-26-000869 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | FORM 4 | 0001470831-26-000738 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | FORM 4 | 0001470831-26-000737 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-28 | FORM 3 | 0001470831-26-000736 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-28 | FORM 3 | 0001470831-26-000735 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-23 | 8-K | 0001628280-26-049937 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0002012383-26-002268 | View SEC Doc Filr Page |
| 4 | 2026-07-14 | 2026-07-10 | FORM 4 | 0001470831-26-000714 | View SEC Doc Filr Page |
| 4 | 2026-07-10 | 2026-07-08 | FORM 4 | 0001470831-26-000701 | View SEC Doc Filr Page |